Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task ForceHolly Pacenta, Theodore W. Laetsch, David M. Langenau et al.|Journal of Clinical Medicine|2021Cited by 28